Mylinax - Novel Therapy for the Treatment of Multiple Sclerosis

Print-Icon
Print

Rebif (interferon-beta 1a) is the number one treatment for multiple sclerosis outside the US.
 
«Back | Next»

Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development